Which IV medication requires specific protocols for handling a hazardous material spill due to its toxicity?

Doxorubicin hydrochloride is classified as a hazardous medication due to its potential toxicity and carcinogenic properties. This chemotherapy agent is used in the treatment of various cancers, and because of its molecular structure and effects on rapidly dividing cells, it poses significant risks if exposed to skin, mucous membranes, or ingested accidentally.

Due to its hazardous nature, there are specific protocols that healthcare facilities must follow for handling spills. These protocols typically involve using personal protective equipment such as gloves and gowns, ensuring that spills are contained promptly using appropriate absorbent materials, and following established guidelines for safe disposal of contaminated materials.

Other medications listed, while they may have specific handling requirements, do not carry the same level of risk for hazardous material spills as doxorubicin hydrochloride. For instance, amiodarone and dopamine are important drugs used in different clinical scenarios but do not necessitate the same stringent hazardous substance protocols related to toxicity or carcinogenicity that applies to doxorubicin.